R J Bio-Tech Ltd
Incorporated in 2005, R J Biotech Limited develops proprietary hybrids with nutritional and economical traits in Fiber crops, Cereal crops and Vegetable crops
- Market Cap ₹ 3.25 Cr.
- Current Price ₹ 3.43
- High / Low ₹ /
- Stock P/E
- Book Value ₹ -53.3
- Dividend Yield 0.00 %
- ROCE %
- ROE %
- Face Value ₹ 10.0
Pros
Cons
- Company has low interest coverage ratio.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Plantation & Plantation Products Industry: Miscellaneous
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
18.39 | 23.14 | 24.63 | 29.69 | 11.91 | 7.04 | 7.73 | 10.21 | 12.65 | 11.34 | 0.00 | 0.00 | |
14.38 | 17.18 | 18.86 | 23.53 | 23.07 | 14.93 | 15.11 | 13.70 | 25.27 | 10.02 | 0.79 | 0.01 | |
Operating Profit | 4.01 | 5.96 | 5.77 | 6.16 | -11.16 | -7.89 | -7.38 | -3.49 | -12.62 | 1.32 | -0.79 | -0.01 |
OPM % | 21.81% | 25.76% | 23.43% | 20.75% | -93.70% | -112.07% | -95.47% | -34.18% | -99.76% | 11.64% | ||
0.00 | 0.00 | 0.00 | 0.00 | 0.06 | -8.69 | 0.14 | 0.21 | -2.97 | 0.52 | 0.55 | 0.00 | |
Interest | 2.34 | 2.64 | 3.60 | 3.44 | 3.60 | 3.89 | 4.14 | 0.78 | 0.00 | 5.82 | 0.00 | 0.00 |
Depreciation | 0.36 | 0.45 | 0.70 | 0.44 | 0.32 | 0.30 | 0.15 | 0.10 | 0.09 | 0.07 | 0.01 | 0.01 |
Profit before tax | 1.31 | 2.87 | 1.47 | 2.28 | -15.02 | -20.77 | -11.53 | -4.16 | -15.68 | -4.05 | -0.25 | -0.02 |
Tax % | 0.00% | 0.00% | 0.00% | 0.44% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
1.30 | 2.87 | 1.46 | 2.27 | -15.02 | -20.77 | -11.53 | -4.16 | -15.68 | -4.05 | -0.25 | -0.01 | |
EPS in Rs | 1.87 | 3.03 | 1.54 | 2.40 | -15.86 | -21.94 | -12.18 | -4.39 | -16.56 | -4.28 | -0.26 | -0.01 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | % |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 15% |
3 Years: | 26% |
TTM: | 99% |
Stock Price CAGR | |
---|---|
10 Years: | -20% |
5 Years: | -23% |
3 Years: | -21% |
1 Year: | 0% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | % |
Balance Sheet
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2024 | Sep 2022 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 6.97 | 9.47 | 9.47 | 9.47 | 9.47 | 9.47 | 9.47 | 9.47 | 9.47 | 9.47 | 9.47 | |
Reserves | 7.51 | 12.88 | 14.23 | 16.50 | 1.49 | -19.28 | -30.81 | -34.97 | -50.65 | -59.81 | -59.96 | |
19.80 | 24.77 | 26.81 | 24.86 | 29.63 | 37.25 | 41.50 | 42.10 | 40.54 | 51.14 | 51.14 | ||
6.28 | 10.90 | 10.36 | 9.06 | 6.94 | 7.64 | 7.62 | 8.82 | 6.50 | 1.11 | 0.91 | ||
Total Liabilities | 40.56 | 58.02 | 60.87 | 59.89 | 47.53 | 35.08 | 27.78 | 25.42 | 5.86 | 1.91 | 1.56 | |
2.91 | 2.99 | 2.41 | 2.12 | 1.95 | 1.84 | 1.75 | 1.72 | 1.75 | 1.53 | 1.40 | ||
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
37.65 | 55.03 | 58.46 | 57.77 | 45.58 | 33.24 | 26.03 | 23.70 | 4.11 | 0.38 | 0.16 | ||
Total Assets | 40.56 | 58.02 | 60.87 | 59.89 | 47.53 | 35.08 | 27.78 | 25.42 | 5.86 | 1.91 | 1.56 |
Cash Flows
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
3.88 | -5.12 | 2.47 | 5.79 | 0.07 | -2.69 | 0.84 | 0.71 | 1.96 | -4.72 | 0.70 | -0.80 | |
-2.37 | -2.18 | -1.66 | -1.35 | -0.84 | -0.82 | -0.77 | -0.67 | -0.37 | 0.00 | 0.09 | 0.00 | |
-2.67 | 7.63 | -0.95 | -4.84 | 0.82 | 3.45 | -0.03 | -0.06 | -1.54 | 4.68 | 0.00 | 0.00 | |
Net Cash Flow | -1.16 | 0.33 | -0.14 | -0.40 | 0.05 | -0.05 | 0.04 | -0.02 | 0.05 | -0.04 | 0.79 | -0.80 |
Ratios
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 172.48 | 179.35 | 238.15 | 294.07 | 581.67 | 862.73 | 473.13 | 263.47 | 23.95 | 9.01 | ||
Inventory Days | 1,122.61 | 1,197.91 | 1,367.74 | 765.29 | 688.99 | 636.64 | 798.33 | 836.97 | 30.46 | 0.00 | ||
Days Payable | 45.83 | 114.67 | 107.48 | 63.88 | 54.78 | 157.17 | 150.67 | 170.45 | 11.60 | |||
Cash Conversion Cycle | 1,249.25 | 1,262.58 | 1,498.40 | 995.47 | 1,215.88 | 1,342.20 | 1,120.79 | 929.99 | 42.80 | 9.01 | ||
Working Capital Days | 541.25 | 635.83 | 672.06 | 575.59 | 1,126.87 | 1,236.02 | 780.05 | 472.96 | -64.34 | -8.05 | ||
ROCE % | 10.95% | 13.54% | 10.39% | 11.29% | -25.11% | -23.67% | -31.05% | -18.88% | -159.27% | 2,400.00% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Change in Management
27 Jan - Resignation of multiple directors and CFO due to liquidation.
-
Announcement under Regulation 30 (LODR)-Change in Management
27 Jan - Change in management and directorship due to liquidation.
-
Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)
26 Oct 2024 - Confirmation of sale of RJ Biotech Limited as a going concern.
-
Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)
25 Oct 2024 - Confirmation of sale of RJ Biotech Limited in liquidation.
- Financial Results For The Period Ended On 31St March,2023 And 31St March, 2024 19 Jul 2024
Business Overview:[1]
Company is an agri-biotechnology company engaged in research, production, marketing of hybrid seeds of various field crops and vegetable crops. Company is a part of Aurangabad based RJ Group which has presence in various businesses viz.
poultry breeding, poultry feeds, fertilizers, pesticides, biotechnology and infrastructure.